Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Evidence of comparative efficacy should have a formal role in European drug approvals

8 references·1 citing·43 second hop

FromToDepth

this work references cited by second hop

References

2009Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews396 cited
2010Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers174 cited
2011Availability of Comparative Efficacy Data at the Time of Drug Approval in the United States71 cited
2006An update on the first decade of the European centralized procedure: how many innovative drugs?68 cited
2007How can we regulate medicines better?58 cited
2006Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization54 cited
2011Ensuring safe and effective drugs: who can do what it takes?43 cited
2011Access to clinical trial data27 cited

Cited by

2019Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis251 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work